Public Grants & Innovation Funding | Venture & Growth Capital | Licensing & Commercial Revenue
The development of ATMPs requires substantial financial resources over many years. Different sources of funding support the product at different stages, including public grants and innovation funding in the early phases, venture and growth capital during development, and commercial revenues or licensing agreements as the therapy approaches the market. Securing adequate funding throughout the development journey is essential to sustain research, clinical studies, manufacturing scale-up, and commercialization.
CO-AX Accelerator
A startup accelerator that helps identify, develop, and scale innovative health technology. They offer tailored support and industry connections founders need to turn health innovation ideas into real world impact.
Workshop: Secure the right competencies to your SME
Do you want to ensure that your company has the right skills for the future? Strengthen your organization’s skills and capabilities through a workshop tailored to your needs. The content can be adapted to your company’s specific challenges, priorities, and development goals.
Research Institute of Sweden – RISE
RISE is Sweden's research institute. They help industry and the public sector develop products, processes or entire operations for a sustainable future. RISE supports both SMEs and researchers in the ATMP field, offering expertise across the entire development process, including in vitro and in vivo research, regulatory guidance, testing and validation, and coordination of collaborative activities where needed.
Synergon
Synergon offers strategic IP advice and practical management of patents, trademarks, and trade secrets. Our strength lies in pharmaceuticals, biotechnology, and medical technology, as well as digital innovations. We ensure that you receive cost-effective and commercially relevant IP protection for your business.
CCRM Nordic
CCRM Nordic, based in Gothenburg, Sweden, supports academic, small, and large industrial ATMP developers to translate research and early-stage clinical programs into treatments for patients.